🔎 Trials Near Me

Home › Chronic Progressive Multiple Sclerosis › Texas

Pag-aaral pangklinika para sa Chronic Progressive Multiple Sclerosis sa Texas

5 pag-aaral para sa Chronic Progressive Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  • Lone Star Neurology, San Antonio
  • Texas Institute for Neurological Disorders - Sherman, Sherman
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07299019

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  • Lone Star Neurology, San Antonio
  • Texas Institute for Neurological Disorders - Sherman, Sherman
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07067463

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 107, Dallas
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07840326

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  • University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology, Dallas
  • Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center, Houston
Nagre-recruitPhase 3
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT04047628

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Carum Research, Dallas
  • Saturn Research Solution, Plano
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07225504

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.